NicOx to halve HQ workforce
November 4, 2010Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs
French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …
Senior creative promotions at Woolley Pau
November 4, 2010Medical Communications Eric Houseknecht, Woolley Pau, Yvette Cumbers, appointment, medical communications
Woolley Pau has promoted senior copywriter Yvette Cumbers and senior art director Eric Houseknecht to the level of deputy creative …
Doctors.net.uk boosts business development team
November 4, 2010Sales and Marketing Doctors.net.uk, Jo Bell, Lizzie Evans, Paul Kelly, Phil Oldroyd, appointment, sales and marketing
Online healthcare professional network Doctors.net.uk has made three business development appointments and added a new project manager to its team. …
CME Spotlight: Making European CME work
November 4, 2010Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak
Since spring I have been dealing with a team of builders who have missed every deadline possible, to the extent …
Biogen set to axe 650 jobs and focus on neurology
November 4, 2010Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs
Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …
UK pharma to declare doctor payments
November 4, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, advisory boards, healthcare professionals, pharma industry standards
Pharma companies in the UK have agreed to restrict their promotional giveaways and to declare payments to doctors. Another common …
New Commercial Realities
November 4, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, pharmaceutical companies must undertake a fundamental and …
Digital Pharma: Diabetes patients and Facebook
November 3, 2010Medical Communications Digital Pharma blog, Facebook, diabetes, patient information, social networking
A quarter of comments on the 15 largest Facebook communities for diabetes patients are promotional – generally for non-FDA approved …
Medivir appoints Charlotte Edenius
November 3, 2010Research and Development Charlotte Edenius, Medivir, appointment, research and development
Swedish specialty pharmaceutical company Medivir has appointed Charlotte Edenius to the newly created position of VP of research and development …
The utility of next generation sequencing in drug development
November 3, 2010Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing
Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …
BMS skin cancer drug hits US regulatory delay
November 3, 2010Research and Development BMS, Bristol-Myers Squibb, FDA, MDX010-020 trial, ipilimumab, skin cancer
US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …
Lundbeck issues Lexapro patent warning
November 3, 2010Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine
Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …
Almirall and Forest’s phase III COPD drug misses goal
November 3, 2010Research and Development Aclidinium bromide, Almirall, COPY, Forest, Forest Laboratories, chronic obstructive pulmonary disease
Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …
Pfizer Q3 profits hit hard
November 3, 2010Sales and Marketing Liptior sales, Pfizer, Pfzier Q3 results, Wyeth
The integration of Wyeth into Pfizer continues to drive its revenue growth, but at a cost – charges from the …
Lonza says contract manufacturing business is recovering
November 2, 2010Manufacturing and Production API, Lonza, contract manufacturing, pharma manufacturing
Lonza said its contract manufacturing business seems to be enjoying a return to form in the third quarter, despite continued …
Pfizer pulls more Lipitor over odour problem
November 2, 2010Manufacturing and Production Lipitor, Lipitor recall, Pfizer, manufacturing compliance, recalls
Pfizer has widened its Lipitor recall after yet another incident in which consumers reported a musty smell emanating from bottles …
Lilly to open diabetes research centre in China
November 2, 2010Research and Development China, Eli Lilly & Co, Lilly Research Laboratories in China, diabetes, lilly
The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …
Nycomed expands China presence with Techpool stake
November 2, 2010Research and Development, Sales and Marketing China, Guangdong Techpool biopharma, Nycomed, emerging markets, emerging pharma markets
Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …
BMS faces approval block unless GMP issues are resolved
November 2, 2010Manufacturing and Production BMS, Bristol-Myers Squibb, FDA, Puerto Rico, belatacept, manufacturing compliance, pharma manufacturing
Bristol-Myers Squibb has been threatened with a block on approvals of certain new drugs, including a biologic for preventing organ …
Lundbeck UK appoints senior management team
November 2, 2010Research and Development, Sales and Marketing Amanda Badrick, Andy Davis, Andy Jones, Helen Carberry, Lundbeck, Steve Ferguson, appointment, recruitment, research and development, sales and marketing
Lundbeck UK has formed a new senior management team, appointing Steve Ferguson, Andy Davis, Andy Jones, Helen Carberry and Amanda …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
